| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Feb 29, 2024 | Aurinia Pharmaceuticals Inc. | EVP, Research and Development | Sell | 26.3 | -4,930 | -1.52% | ✗ | $30.1K |
| Feb 20, 2024 | Feb 22, 2024 | Aurinia Pharmaceuticals Inc. | EVP, Research and Development | Sell | 42.5 | -25,146 | -7.20% | ✗ | $137.8K |